{"nct_id":"NCT01392326","title":"Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)","status":"COMPLETED","status_verified_date":"2016-01","start_date":"2011-09","start_date_type":null,"primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}